F Addad1, J Gouider2, E Boughzela3, S Kamoun4, R Boujenah5, H Haouala6, H Gamra7, F Maatouk8, A Ben Khalfallah9, S Kachboura10, H Baccar11, N Ben Halima12, A Guesmi13, K Sayahi14, W Sdiri15, A Neji16, A Bouakez17, K Battikh18, R Chettaoui19, S Mourali20. 1. Service de cardiologie, CHU Abderrahmen Mami, Ariana, Tunisie. Electronic address: secretaire.stcccv@gmail.com. 2. CHU Farhat Hached, Sousse, Tunisie. 3. CHU de Sahloul, Sousse, Tunisie. 4. CHU Hédi Chaker, Sfax, Tunisie. 5. CHU Mongi Slim, Marsa, Tunisie. 6. Hôpital Militaire Principal d'Instruction de Tunis, Tunis, Tunisie. 7. Cardio A CHU Fattouma Bourguiba, Monastir, Tunisie. 8. Cardio B CHU Fattouma Bourguiba, Monastir, Tunisie. 9. Hôpital de Menzel Bourguiba, Menzel Bourguiba, Tunisie. 10. Service de cardiologie, CHU Abderrahmen Mami, Ariana, Tunisie. 11. Hôpital Chrales Nicolles, Tunis, Tunisie. 12. Hôpital régional Ibn El Jazzar, Kairouan, Tunisie. 13. Hôpital régional Mohamed Ben Sassi, Gabes, Tunisie. 14. Hôpital régional M'Hamed Bourguiba, Kef, Tunisie. 15. Hôpital régional Habib Bougatfa, Bizerte, Tunisie. 16. Hôpital régional Ben Guerdene, Médenine, Tunisie. 17. Hôpital régional Jendouba, Jendouba, Tunisie. 18. Clinique de Jerba, Jerba, Tunisie. 19. Clinique de Tunis, Tunis, Tunisie. 20. CHU La Rabta, Tunis, Tunisie.
Abstract
UNLABELLED: FAST-MI Tunisian registry was initiated by the Tunisian Society of Cardiology and Cardio-vascular Surgery to assess characteristics, management, and hospital outcomes in patients with ST-elevation myocardial infarction (STEMI). METHODS: We prospectively collected data from 203 consecutive patients (mean age 60.3 years, 79.8 % male) with STEMI who were treated in 15 public hospitals (representing 68.2 % of Tunisian public centres treating STEMI patients) during a 3-month period at the end of 2014. The most common risk factor was tobacco (64.9 %), hypertension (38.6 %), diabetes (36.9 %) and dyslipidemia (24.6 %). RESULTS: Among these patients, 66 % received reperfusion therapy, 35 % with primary percutaneous coronary interventions (PAMI), 31 % with thrombolysis (28.6 % of them by pre-hospital thrombolysis). The median time from symptom onset to thrombolysis was 185 and 358 min for PAMI, respectively. The in-hospital mortality was 7.0 %. Patients enrolled in interventional centers (n=156) were more likely to receive any reperfusion therapy (19.8 % vs 44.6 %; p<0.001) than at the regional system of care with less thrombolysis (26.9 % vs 44.6 %; p=0.008) and more PAMI (52.8 % vs 8.5 %; p<0.0001). Also the in-hospital mortality was lower (6.4 % vs 9.3 %) but not significant. CONCLUSIONS: Preliminary results from FAST-MI in Tunisia show that the pharmaco- invasive strategy should be promoted in non-interventional centers.
UNLABELLED: FAST-MI Tunisian registry was initiated by the Tunisian Society of Cardiology and Cardio-vascular Surgery to assess characteristics, management, and hospital outcomes in patients with ST-elevation myocardial infarction (STEMI). METHODS: We prospectively collected data from 203 consecutive patients (mean age 60.3 years, 79.8 % male) with STEMI who were treated in 15 public hospitals (representing 68.2 % of Tunisian public centres treating STEMI patients) during a 3-month period at the end of 2014. The most common risk factor was tobacco (64.9 %), hypertension (38.6 %), diabetes (36.9 %) and dyslipidemia (24.6 %). RESULTS: Among these patients, 66 % received reperfusion therapy, 35 % with primary percutaneous coronary interventions (PAMI), 31 % with thrombolysis (28.6 % of them by pre-hospital thrombolysis). The median time from symptom onset to thrombolysis was 185 and 358 min for PAMI, respectively. The in-hospital mortality was 7.0 %. Patients enrolled in interventional centers (n=156) were more likely to receive any reperfusion therapy (19.8 % vs 44.6 %; p<0.001) than at the regional system of care with less thrombolysis (26.9 % vs 44.6 %; p=0.008) and more PAMI (52.8 % vs 8.5 %; p<0.0001). Also the in-hospital mortality was lower (6.4 % vs 9.3 %) but not significant. CONCLUSIONS: Preliminary results from FAST-MI in Tunisia show that the pharmaco- invasive strategy should be promoted in non-interventional centers.
Authors: Faouzi Addad; Abdallah Mahdhaoui; Jeridi Gouider; Essia Boughzela; Samir Kamoun; Mohamed Rachid Boujnah; Habib Haouala; Habib Gamra; Faouzi Maatouk; Ali Ben Khalfallah; Salem Kachboura; Hedi Baccar; Nejeh Ben Halima; Ali Guesmi; Khaled Sayahi; Wissem Sdiri; Ali Neji; Ahmed Bouakez; Sami Milouchi; Kais Battikh; Yves Jullieres; Nicolas Danchin; Jean Jacques Monsuez; Genevieve Mulak; Albert Hagege; Vincent Bataille; Rafik Chettaoui; Mohamed Sami Mourali Journal: PLoS One Date: 2019-02-22 Impact factor: 3.240